Yüklüyor......
Targeting B cells in systemic lupus erythematosus: not just déjà vu all over again
Epratuzumab (anti-CD22) is a humanized monoclonal antibody that recognizes a pan-B-cell marker. It potentially downregulates B cell activity through negative signaling, as well as depleting B cells moderately. The uncontrolled series discussed by Dörner and colleagues in this issue of Arthritis Rese...
Kaydedildi:
| Yazar: | |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2006
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1526641/ https://ncbi.nlm.nih.gov/pubmed/16732895 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/ar1967 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|